312 related articles for article (PubMed ID: 30092752)
1. Medicinal cannabis in Australia, 2016: the Cannabis as Medicine Survey (CAMS-16).
Lintzeris N; Driels J; Elias N; Arnold JC; McGregor IS; Allsop DJ
Med J Aust; 2018 Aug; 209(5):211-216. PubMed ID: 30092752
[TBL] [Abstract][Full Text] [Related]
2. Medical cannabis use in the Australian community following introduction of legal access: the 2018-2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18).
Lintzeris N; Mills L; Suraev A; Bravo M; Arkell T; Arnold JC; Benson MJ; McGregor IS
Harm Reduct J; 2020 Jun; 17(1):37. PubMed ID: 32513180
[TBL] [Abstract][Full Text] [Related]
3. Medical cannabis use in Australia seven years after legalisation: findings from the online Cannabis as Medicine Survey 2022-2023 (CAMS-22).
Mills L; Arnold JC; Suraev A; Abelev SV; Zhou C; Arkell TR; McGregor IS; Lintzeris N
Harm Reduct J; 2024 May; 21(1):104. PubMed ID: 38807133
[TBL] [Abstract][Full Text] [Related]
4. Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20).
Lintzeris N; Mills L; Abelev SV; Suraev A; Arnold JC; McGregor IS
Harm Reduct J; 2022 Jul; 19(1):88. PubMed ID: 35907959
[TBL] [Abstract][Full Text] [Related]
5. Exploring medicinal use of cannabis in a time of policy change in New Zealand.
Rychert M; Wilkins C; Parker K; Graydon-Guy T
N Z Med J; 2020 May; 133(1515):54-69. PubMed ID: 32438377
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and correlates of cannabis use disorder among Australians using cannabis products to treat a medical condition.
Mills L; Lintzeris N; O'Malley M; Arnold JC; McGregor IS
Drug Alcohol Rev; 2022 Jul; 41(5):1095-1108. PubMed ID: 35172040
[TBL] [Abstract][Full Text] [Related]
7. Medical Cannabis Use Patterns for Sleep Disorders in Australia: Results of the Cross-Sectional CAMS-20 Survey.
Suraev A; Mills L; Abelev SV; Arkell TR; Lintzeris N; McGregor IS
Nat Sci Sleep; 2023; 15():245-255. PubMed ID: 37090897
[TBL] [Abstract][Full Text] [Related]
8. Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study.
Campbell G; Hall WD; Peacock A; Lintzeris N; Bruno R; Larance B; Nielsen S; Cohen M; Chan G; Mattick RP; Blyth F; Shanahan M; Dobbins T; Farrell M; Degenhardt L
Lancet Public Health; 2018 Jul; 3(7):e341-e350. PubMed ID: 29976328
[TBL] [Abstract][Full Text] [Related]
9. Cannabis Enthusiasts' Knowledge of Medical Treatment Effectiveness and Increased Risks From Cannabis Use.
Kruger DJ; Kruger JS; Collins RL
Am J Health Promot; 2020 May; 34(4):436-439. PubMed ID: 31916839
[TBL] [Abstract][Full Text] [Related]
10. Cannabis Use for Endometriosis: Clinical and Legal Challenges in Australia and New Zealand.
Sinclair J; Toufaili Y; Gock S; Pegorer AG; Wattle J; Franke M; Alzwayid MAKM; Abbott J; Pate DW; Sarris J; Armour M
Cannabis Cannabinoid Res; 2022 Aug; 7(4):464-472. PubMed ID: 34978929
[No Abstract] [Full Text] [Related]
11. An Australian nationwide survey on medicinal cannabis use for epilepsy: History of antiepileptic drug treatment predicts medicinal cannabis use.
Suraev AS; Todd L; Bowen MT; Allsop DJ; McGregor IS; Ireland C; Lintzeris N
Epilepsy Behav; 2017 May; 70(Pt B):334-340. PubMed ID: 28238865
[TBL] [Abstract][Full Text] [Related]
12. Medical Cannabis Users' Comparisons between Medical Cannabis and Mainstream Medicine.
Kruger DJ; Kruger JS
J Psychoactive Drugs; 2019; 51(1):31-36. PubMed ID: 30616501
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and correlates of non-medical only compared to self-defined medical and non-medical cannabis use, Canada, 2015.
Rotermann M; Pagé MM
Health Rep; 2018 Jul; 29(7):3-13. PubMed ID: 30020531
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic use of cannabis: Prevalence and characteristics among adults in Ontario, Canada.
Hamilton HA; Brands B; Ialomiteanu AR; Mann RE
Can J Public Health; 2017 Sep; 108(3):e282-e287. PubMed ID: 28910251
[TBL] [Abstract][Full Text] [Related]
15. Clinical trials of medicinal cannabis for appetite-related symptoms from advanced cancer: a survey of preferences, attitudes and beliefs among patients willing to consider participation.
Luckett T; Phillips J; Lintzeris N; Allsop D; Lee J; Solowij N; Martin J; Lam L; Aggarwal R; McCaffrey N; Currow D; Chye R; Lovell M; McGregor I; Agar M
Intern Med J; 2016 Nov; 46(11):1269-1275. PubMed ID: 27530738
[TBL] [Abstract][Full Text] [Related]
16. Marijuana use among patients with epilepsy at a tertiary care center.
Kerr A; Walston V; Wong VSS; Kellogg M; Ernst L
Epilepsy Behav; 2019 Aug; 97():144-148. PubMed ID: 31252269
[TBL] [Abstract][Full Text] [Related]
17. Off-Label Use of Phosphodiesterase Type 5 Inhibitor Erectile Dysfunction Medication to Enhance Sex Among Gay and Bisexual Men in Australia: Results From the FLUX Study.
Hammoud MA; Jin F; Lea T; Maher L; Grierson J; Prestage G
J Sex Med; 2017 Jun; 14(6):774-784. PubMed ID: 28583339
[TBL] [Abstract][Full Text] [Related]
18. Loose regulation of medical marijuana programs associated with higher rates of adult marijuana use but not cannabis use disorder.
Williams AR; Santaella-Tenorio J; Mauro CM; Levin FR; Martins SS
Addiction; 2017 Nov; 112(11):1985-1991. PubMed ID: 28600874
[TBL] [Abstract][Full Text] [Related]
19. Knowledge and attitudes of Australian general practitioners towards medicinal cannabis: a cross-sectional survey.
Karanges EA; Suraev A; Elias N; Manocha R; McGregor IS
BMJ Open; 2018 Jul; 8(7):e022101. PubMed ID: 29970456
[TBL] [Abstract][Full Text] [Related]
20. Cannabis Use, a Self-Management Strategy Among Australian Women With Endometriosis: Results From a National Online Survey.
Sinclair J; Smith CA; Abbott J; Chalmers KJ; Pate DW; Armour M
J Obstet Gynaecol Can; 2020 Mar; 42(3):256-261. PubMed ID: 31722852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
